Exelixis (EXEL) Accounts Payables (2010 - 2026)

Exelixis' (EXEL) quarterly Accounts Payables came in at $24.2 million in Q2 2026, down 43.62% year-on-year from $42.8 million in Q2 2025, and down 18.46% quarter-over-quarter from $29.6 million in Q1 2026.

Exelixis (EXEL) Accounts Payables (2010 - 2026) Analysis & Trends

Exelixis' Accounts Payables history runs 17 years deep, the most recent figure standing at $24.2 million for Q2 2026.

  • On a quarterly basis, Accounts Payables fell 43.62% year-over-year to $24.2 million in Q2 2026; TTM through Apr 2026 was $24.2 million, a 43.62% decrease from a year earlier, with the FY2026 full-year figure at $29.6 million, down 22.43% from the prior year.
  • Accounts Payables fell to $24.2 million in Q2 2026 per EXEL's latest filing, from $29.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $59.3 million in Q3 2024 and bottomed at $17.3 million in Q2 2022.
  • The 5-year median for Accounts Payables is $28.7 million (2024), against an average of $30.6 million.
  • Across the five-year window, Accounts Payables jumped 124.23% in 2024 and slumped 57.26% in 2025, its largest moves.
  • Year by year, Accounts Payables stood at $32.7 million in 2022, then advanced by 3.37% to $33.8 million in 2023, then surged by 75.64% to $59.3 million in 2024, then slumped by 57.26% to $25.3 million in 2025, then fell by 4.71% to $24.2 million in 2026.
  • Per Business Quant, the three latest EXEL Accounts Payables figures stand at $24.2 million (Q2 2026), $29.6 million (Q1 2026), and $25.3 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 5.74 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 10.62 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 423.55 Mn
4 NuCana 279.75 Bn 279.75 Bn - 694,346.76
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.52 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 80.54 Mn
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 24.15 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 24.15 Mn
Jan 2, 2026 29.62 Mn
Oct 3, 2025 25.35 Mn
Jul 4, 2025 25.82 Mn
Apr 4, 2025 42.84 Mn
Jan 3, 2025 38.19 Mn
Sep 27, 2024 59.31 Mn
Jun 28, 2024 28.68 Mn
Mar 29, 2024 26.07 Mn
Dec 29, 2023 33.77 Mn
Sep 29, 2023 26.45 Mn
Jun 30, 2023 25.99 Mn
Mar 31, 2023 32.62 Mn
Dec 30, 2022 32.67 Mn
Sep 30, 2022 30.57 Mn
Jul 1, 2022 19.98 Mn
Apr 1, 2022 17.29 Mn
Dec 31, 2021 24.26 Mn
Oct 1, 2021 24.31 Mn
Jul 2, 2021 20.45 Mn